SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pharmacopeia, Inc. (ACCL) (Prev: PCOP)
An SI Board Since May 1997
Posts SubjectMarks Bans Symbol
179 14 0 ACCL
Emcee:  Jim Lang Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
54 All, Does anyone know if MSIM has been profitable, and/or how it will affect tJim Lang-2/5/1998
53 Jim, I second your request. Here is the Molecular Simulations website: msi.comkinkblot-2/5/1998
52 Sue, Saw your announced purchase of MSIM. Now I know you're censured but James Silverman-2/5/1998
51 Sue, So much for the no patent argument. This is a very broad claim relating James Silverman-2/2/1998
50 Larry, Some other firms that follow Pharmacopeia are Lehman Brothers, Cowen, Ukinkblot-2/2/1998
49 I came across a "strong buy" recommendation from Alex Brown 4/97 for Larry Liebman-2/1/1998
48 Peter, Pharmacopeia discusses competing technologies in their 1996 Form 10-K, kinkblot-1/14/1998
47 Affymax Receives Patent for Encoded Combinatorial Library Technology biz.yahooPeter Silsbee-1/13/1998
46 Sue, Although I personally do not see how participation here is any different Jim Lang-12/9/1997
45 Rick, I'm not sure what sentiment you and Jim agree with. If you are refeSusan Rodney-12/8/1997
44 Sue, Congratulations on the nice looking deal with BMY! I'll echo Rick'James Silverman-12/2/1997
43 Susan: Sorry to see you go. I think that we all came to the same conclusion tscaram(o)uche-12/2/1997
42 James, I'd love to respond but unfortunately I'm being censored! I&#Susan Rodney-11/25/1997
41 Sue, Don't get me wrong, I like your company, what you are doing and how mJames Silverman-11/24/1997
40 Susan, thanks for taking the time to add to this thread - one of the few (intelNight Trader-11/21/1997
39 John, I'm pleased to be participating in the thread and hope that it proviSusan Rodney-11/13/1997
38 Jim, I appreciate your response and thought it might be helpful to clarify a fSusan Rodney-11/13/1997
37 I'm not sure what you mean by "classical" in this sense. Many gooJohn Dwyer-11/11/1997
36 John I agree with you that both companies are wortwile bet for the future. Askermagoret-11/11/1997
35 Hi Sue, Thanks for your reply. I think that the combichem field is certainly John Dwyer-11/11/1997
34 Sue, Just wanted to reply piecemeal to your post contrasting the virtues of PCJames Silverman-11/10/1997
33 John, I'm glad that you are finding our website useful. We too think thatSusan Rodney-11/7/1997
32 Hi Susan, Glad to have you on the thread. I have followed PCOP and ArQule forJohn Dwyer-11/6/1997
31 As the investor relations manager of Pharmacopeia, I wanted to mention that we Susan Rodney-10/31/1997
30 Sorry this response is so delayed. I am Pharmacopeia's Manager of InvestorSusan Rodney-10/31/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News